Study Stopped
No participants enrolled; study inactivated
Cost Analysis for Endoscopic Retrograde Cholangiopancreatography (ERCP)
ERCP
The Impact of Cost Itemization on Resource Utilization With ERCP
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of the study is to determine if endoscopist notification of accessory cost results in altered resource utilization related to the total cost and number of accessories used in ERCP. This study will be a prospective cost--analysis study. Only chart review of PHI removed records will be used. The only intervention used is that endoscopists will be made aware of the cost of accessories used in the second phase of the study following each ERCP. The investigators are in an era of increased medical cost consciousness. Medical education and post--graduate education incorporates cost savings and appropriate diagnostic test selection based on expense as one aspects of the decision process. This era now focuses on what is best for the patient with the understanding that the cost to the patient and cost to the overall health care system matters. Not only is this apart of postgraduate training but now being implemented as part of Medicare reimbursement to provide low cost and high quality care. Incidence of pancreatic and biliary disease is increasing. ERCP is a vital tool for therapeutic intervention. The costs of these procedures, to both patients and hospitals, have caused some to question the amount of accessories used as well as the poor reimbursement provided by Medicare and insurers. Studies have indicated that hospitals actually lose money with each ERCP used and their use is being limited many times to tertiary care centers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Apr 2014
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 4, 2014
CompletedStudy Start
First participant enrolled
April 1, 2014
CompletedFirst Posted
Study publicly available on registry
April 30, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedAugust 28, 2017
August 1, 2017
5 months
March 4, 2014
August 25, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reduction of total cost of disposable accessories used for individual ERCP procedures
Two arms in the study. One arm is observation of blinding endoscopists and calculating cost of disposable accessories used while performing ERCP. The other arm will be the intervention group. Before the intervention period begins, advanced endoscopists will be informed that there cost is being monitored for each ERCP and the cost of disposable accessories. Following each ERCP during the intervention group, the endoscopists will be informed of the cost of that individual procedure based on disposable accessories.
ERCP procedures will be observed for up to 3 months for each arms of study
Secondary Outcomes (1)
Cost identification of disposable accessory use in ERCP
ERCP procedures will be observed for up to 3 months for each arms of study
Study Arms (2)
Blinded observation of ERCP
NO INTERVENTIONBlind observation of disposable accessories use.
Endoscopist informed of cost per procedure
EXPERIMENTALEndoscopists informed following each ERCP.
Interventions
Following each procedure, endoscopists will get a cost report regarding the amount spent on disposable accessories.
Eligibility Criteria
You may qualify if:
- Adult receiving ERCP at Endoscopy diagnostic center.
You may not qualify if:
- No stent removal or replacement procedures. EUS can only be used for intubation of bile duct. No spyglass will added to total cost.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Oklahoma Health Science Center
Oklahoma City, Oklahoma, 73104, United States
Study Officials
- PRINCIPAL INVESTIGATOR
William Tierney, MD
University of Oklahoma
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2014
First Posted
April 30, 2014
Study Start
April 1, 2014
Primary Completion
September 1, 2014
Study Completion
September 1, 2014
Last Updated
August 28, 2017
Record last verified: 2017-08